@drsgraff : Now in print, an important analysis asking if high disease burden, premenopausal metastatic breast cancer needs chemo, or can be treated with CDK4/6 Inhibitors. #RIGHTChoice—Ribociclib+ET vs chemo—now in @JCO_ASCO @OncoAlert #bcsm ascopubs.org/doi/150.1200/JC… • TwiCopy

Stephanie Graff, MD, FACP, FASCO

@drsgraff

+ Follow

Director Breast Oncology, Lifespan Cancer Institute | Assoc Prof Legorreta Cancer Center Brown Univ | Views Mine | vivo.brown.edu/display/sgraff | COI ⬇

ID: 838389180484898816

linkhttps://coi.asco.org/share/NPU-PUCW/Stephanie%20Graff calendar_today05-03-2017 14:02:11

14,14K Tweet

19,19K Followers

3,3K Following

Stephanie Graff, MD, FACP, FASCO

@drsgraff

4 months ago

Now in print, an important analysis asking if high disease burden, premenopausal metastatic breast cancer needs chemo, or can be treated with CDK4/6 Inhibitors. #RIGHTChoice—Ribociclib+ET vs chemo—now in Journal of Clinical Oncology OncoAlert #bcsm ascopubs.org/doi/10.1200/JC…